Cell Dissociation Market with COVID-19 Impact Analysis,By Product (Enzymatic Dissociation Products Trypsin Papain Hyaluronidase Elastase DNase Collagenase Other Enzymes Enzymatic Dissociation Products Instruments), By Tissues (Connective Tissues Epithelial Tissues), By Type (Tissue dissociation Cell detachment), By End User (Pharmaceutical and Biotechnology companies Research and Academics), and by Region (NA, EU, APAC, LA, MEA) Analysis, Size, Share, Trends, & Forecast from 2021-2027
REPORT HIGHLIGHT
The global Cell Dissociation market was valued at USD 285.2 million in 2020, growing with 13.1% CAGR during the forecast period, 2021-2027.
Trypsinization is the term for the process of cell separation. A proteolytic enzyme converts proteins to detach adherent cells from the container in that they are cultivated using the cell separation process. The proteolytic enzyme is used to divide the proteins to detach adherent cells from the vessel as they are refined. Furthermore, the cell dissociation chemicals have a stiffness of the material and proteolytic activity to detach tissues and v cell lines from glass or plastic surfaces, resulting in higher isolation efficiency and cell survival.
Market Dynamics
The biopharmaceutical business is a fast-growing area of the pharmaceutical sector, with huge ramifications for healthcare. As a result of the high efficacy and safety of these treatments, opportunities in biopharma have grown during the last decade. Biopharmaceuticals have a number of advantages, including very effective and powerful action, lesser side effects, and the possibility to cure diseases rather than just treat symptoms, all of which have boosted demand for biopharmaceuticals.
For competitors in the cell dissociation industry, emerging economies such as China, India, and Brazil are likely to provide considerable growth potential. Due to increased R&D activity in the life sciences industry in these nations, these markets are likely to develop rapidly in the future years. Pharmaceutical businesses in India, for example, are investing heavily in R&D in order to bring new treatments to market. Cadila Healthcare Ltd., an Indian pharmaceutical business, spent USD 113 million on research and development in 2020, up 13% from 2019. Biocon, another Indian pharmaceutical business, spent USD 58.79 million on research and development in 2020, up 52 percent from 2019. The demand for cell dissociation solutions in the nation is likely to rise as a result of these investments.
With the World Health Organization (WHO) labeling the COVID-19 outbreak a pandemic, a number of prominent pharmaceuticals and biomedical firms, as well as tiny startups, have stepped up to create therapies and vaccines to combat the infection caused by the new coronavirus. The COVID-19 pandemic has had a substantial impact on hospital resources across the world. This has mostly been accomplished by drastically lowering inpatient and outpatient care for various diseases, as well as instituting infection control and prevention methods. The number of cancer detection and diagnosis treatments has dropped dramatically, with the epidemic affecting nations all over the world.
Segmentation Analysis:
The Cell Dissociation market is segmented on the basis of Product, Tissue, Type, Tissue, and region.
Enzymes are used in stem cell studies and cell biology investigations for cell and tissue dissociation, primary cell separation, and single-cell harvesting. The employment of enzymes for cell dissociation is very common. Any dissociation process aims to produce as many functionally viable separated cells as possible. The kind of tissue, dissociation media utilized, age of the animal/human, enzyme employed, temperature, enzyme concentration, and genetic alterations all influence the outcome of any dissociation operation.
Tissue dissociation and cell detachment are the two types of cell dissociation. In 2020, the tissue dissociation category accounted for a significant market share. This category's substantial share may be ascribed to rising research and development spending in the biotechnology and pharmaceutical industries, which is driving segment expansion.
The cell dissociation market is divided into three categories based on end-users: research and academics, pharmaceutical and biotechnology sectors, and other end users. In 2020, the pharmaceutical and biotechnology sectors held the greatest proportion of the cell dissociation market. The market's mainly driven due to the factors such as increasing pharmaceutical and biotechnology investments.
North America held the highest proportion of the cell dissociation market in 2020. North America's substantial share is mostly due to increased research in the biotechnology industries, as well as the strong presence of leading market participants in this area. Furthermore, projections for stem cell-based research accessible on the National Institute of Health portal show a total funding allocation of more than USD 3 billion for study in diverse domains of stem cell applications. Furthermore, the presence of a large number of chemical and lab testing providers in the United States, who are capable of offering both enzymatic and non-enzymatic products for cell dissociation, is projected to contribute to the market's expansion.
Competitive Landscape:
The key players include Becton, Dickinson and Company, Thermo Fisher Scientific, Cytiva (a part of Danaher Corporation), Roche Diagnostics, Miltenyi Biotec, STEMCELL Technologies, AcceGen, PromoCell GmbH, Alstem, VitaCyte, Gemini Bio, Biological Industries, Central Drug House, Innovative Cell Technologies, Capricorn Scientific, Worthington Biochemical Corporation, Genlantis, Abeomics, and Neuromics.
In the year 2020, Thermo Fisher Scientific was the market leader. The corporation has a substantial presence in the United States, Europe, Asia, the Middle East, and Africa, as well as the Americas. Furthermore, the company's significant asset in the cell dissociation industry is its excellent brand awareness and broad product portfolio. In 2020, Merck KgaA ranked second in the cell dissociation market.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELL DISSOCIATION MARKET KEY PLAYERS
- Becton
- Dickinson and Company
- Thermo Fisher Scientific
- Cytiva (a part of Danaher Corporation)
- Roche Diagnostics
- Miltenyi Biotec
- STEMCELL Technologies
- AcceGen
- PromoCell GmbH
- Alstem
- VitaCyte
- Gemini Bio
- Biological Industries
- Central Drug House
- Innovative Cell Technologies
- Capricorn Scientific
- Worthington Biochemical Corporation
- Genlantis
- Abeomics
- Neuromics
GLOBAL CELL DISSOCIATION MARKET, BY PRODUCT
- Enzymatic Dissociation Products
- Trypsin
- Papain
- Hyaluronidase
- Elastase
- DNase
- Collagenase
- Other Enzymes
- Enzymatic Dissociation Products
- Instruments
GLOBAL CELL DISSOCIATION MARKET, BY TISSUES
- Connective Tissues
- Epithelial Tissues
- Other
GLOBAL CELL DISSOCIATION MARKET, BY TYPE
- Tissue dissociation
- Cell detachment
GLOBAL CELL DISSOCIATION MARKET, BY END-USER
- Pharmaceutical and Biotechnology companies
- Research and Academics
- Others
GLOBAL CELL DISSOCIATION MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
1. Cell Dissociation Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Market Snippet by Product
2.1.2. Market Snippet by Tissue
2.1.3. Market Snippet by Type
2.1.4. Market Snippet by End User
2.1.5. Market Snippet by Region
2.2. Competitive Insights
3. Cell Dissociation Key Market Trends
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. Cell Dissociation Industry Study
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cell Dissociation Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Cell Dissociation Market Landscape
6.1. Market Share Analysis, 2020
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. Cell Dissociation Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2020 & 2027 (%)
7.2. Enzymatic Dissociation Products
7.2.1. Trypsin
7.2.2. Papain
7.2.3. Hyaluronidase
7.2.4. Elastase
7.2.5. DNase
7.2.6. Collagenase
7.2.7. Other Enzymes
7.3. Enzymatic Dissociation Products
7.4. Instruments
8. Cell Dissociation Market – By Tissue
8.1. Overview
8.1.1. Segment Share Analysis, By Tissue, 2020 & 2027 (%)
8.2. Connective Tissues
8.3. Epithelial Tissues
8.4. Other
9. Cell Dissociation Market – By Type
9.1. Overview
9.1.1. Segment Share Analysis, By Type, 2020 & 2027 (%)
9.2. Tissue dissociation
9.3. Cell detachments
10. Cell Dissociation Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Type, 2020 & 2027 (%)
10.2. Pharmaceutical and Biotechnology companies
10.3. Research and Academics
10.4. Others
11. Cell Dissociation Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
11.2. North America
11.2.1. Overview
11.2.2. Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.2.5. North America Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.2.6. North America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.2.8.7.
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
1.1.1.1. Canada Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
1.1.1.2. Canada Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
1.1.1.3. Canada Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
1.1.1.4. Canada Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.3.12. Rest of Europe
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.3.12.3. Rest of the Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.3.12.4. Rest of the Europe Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.3.12.5. Rest of the Europe Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.3.12.6. Rest of the Europe Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.4.12. Rest of APAC
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.4.12.3. Rest of APAC Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.4.12.4. Rest of APAC Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.4.12.5. Rest of APAC Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.4.12.6. Rest of APAC Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.5.11. Rest of LATAM
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.5.11.4. Rest of LATAM Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.5.11.6. Rest of LATAM Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Tissue, 2016 - 2027 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Type, 2016 - 2027 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2016 - 2027 (US$ Million)
12. Key Vendor Analysis
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Becton, Dickinson and Company
12.2.2. Thermo Fisher Scientific
12.2.3. Cytiva (a part of Danaher Corporation)
12.2.4. Roche Diagnostics
12.2.5. Miltenyi Biotec
12.2.6. STEMCELL Technologies
12.2.7. AcceGen
12.2.8. PromoCell GmbH
12.2.9. Alstem
12.2.10. VitaCyte
12.2.11. Gemini Bio
12.2.12. Biological Industries
12.2.13. Central Drug House
12.2.14. Innovative Cell Technologies
12.2.15. Capricorn Scientific
12.2.16. Worthington Biochemical Corporation
12.2.17. Genlantis
12.2.18. Abeomics
12.2.19. Neuromics
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
